Claims About Fenbendazole and Ivermectin for Cancer

Cancer is actually a parasite, believe it or not, and the

cure costs five dollars.

A drug designed to kill parasitic

worms just helped three

stage four cancer patients into

complete remission. And absolutely no major cancer

center will run a clinical trial on it.

How does a drug that kills

parasites also kill cancer?

At the molecular level,

cancer really is a parasite.

What's very unique about

cancer and parasites

is they both are rapid

dividers. Like even a tapeworm,

for example, can produce fifty

thousand eggs a

day. Cancer cells divide nonstop because they

basically don't have any more

brakes. It's all accelerator.

And so if we take an anti-parasitic drug,

fenbendazole, this

is a drug that grabs onto these little tubular proteins and breaks the

scaffolding down.

And all of these other anti-parasitic

drugs, whether

it's ivermectin, natural herbs

like wormwood, black

walnut hull, and clove, do the

same thing either

directly or indirectly.

So all of these anti-parasitics

inhibit the fuel source for cancer.

And when I was looking into the ivermectin and fenbendazole, I

didn't even realize that the

other herbal natural remedies

that a lot of people take for parasite cleanses

also do a very

similar action indirectly and directly.

The question is, why haven't you heard about this?

Well, first of all, the patents expired years ago,

and no one's gonna

spend a hundred million dollars on a twelve-dollar remedy.

Most of the research, which

I'm gonna put links down below,

are from universities

in South Korea, India, in small labs.

No industry funding, no

conflicts of interest.

There's also quite a bit of published case studies documenting these

antifungal results in stage four

patients with

cancer that have resistance to

chemotherapy.

Another interesting study in two thousand

and twenty-five,

fenbendazole targets regular cancer cells

and cancer stem cells. These are the seeds that survive

chemo and regrow tumors.

A hundred percent survival

in treated mice,

zero in untreated

controls.